Search Results
Results found for "Sai Prasad Pydi"
- Fluorescence Polarization in GPCR Research
References Kumar V, Chunchagatta Lakshman PK, Prasad TK, Manjunath K, Bairy S, Vasu AS, Ganavi B, Jasti
- Science Needs Rigor, But Also Joy
And that moment, silly as it was, says a lot about how he sees science.
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Saying yes to a postdoc opportunity abroad.
- From Pipettes to Platforms: The Evolution of GPCR Research
Like many, it was a mix of opportunity, timing, and the courage to say yes before everything was figured Technical mastery opened doors, but what kept her moving was knowing when to say yes before everything
- How GPCR Spatial Signaling Sparked a Scientific Journey
I didnât expect to love it, says Michelle Halls. But luck only works if you say yes when the door opens.
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Proven frameworks used in real discovery programs On-demand lessons built for tight research schedules A say Access this weekâs full Premium Edition here ⤠What our members say "Thank you for bringing this course
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
âYou can try, try, tryâand fail, fail, fail,â Eric says. âDonât over-rationalize,â he says. At early stages, breadth matters more than precision.
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
 From t-tests to ANOVA and F-tests, know which tool to apply when, so debates about âwhat the graph says Access this weekâs full Premium Edition here ⤠What our members say đŁď¸ "The content had enough depth
- Ben Clements on Rescuing Opioids with GPCR Modulators
where the excitement lies: "Thereâs so much space left to explore in GPCR-targeted modulation," he says
- Curve Shifts Donât Lie, But Your Eyes Might
No more arguments about âwhat the graph seems to say.â Youâll move from âI thinkâ Â to âI know.â The literature says 7.5. Is that consistent, or is your assay biased?
- The Hidden Cost of Ambition in Biotech Leadership
Saying no to those opportunities feels counterintuitive. toward the next decisive milestone, it likely dilutes attention. 2ď¸âŁ What are we implicitly delaying by saying
- From Snapshots to Predictions: Why Mechanism of Action Matters
You can say what the drug âseemsâ to do, but not what it will do elsewhere. Models are the bridge. Instead of saying, âThis looks like partial agonismâ , you can ask: What happens if concentration increases
- The Real Cost of Strategic Overload in Biotech
Saying yes often feels safer than saying no.
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
. đ Founders often look back and say that nothing felt broken. The science was sound. No moment where leadership can clearly say that something went wrong.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⌿ Nov 24 - Dec 1, 2024
Please don't say we didn't give you a heads-up! s dive into the  Classified GPCR News from November 25th to December 1st, 2024 Industry News Amgen says
- GPCR Happy Hour Boston 2026 â April 29 | Dr. GPCR Community Event
hallway between sessions, at the coffee station, or in the ten minutes after a talk when someone finally says
- Beyond HEK293 â Terry HĂŠbert on iPSC-Derived GPCR Models, Live April 16,
Explore the library ⤠What Members Say The scientists in this community hold teaching to the same standard
- Adhesion GPCR Consortium Newsletter - May 2024
As much as I was shocked that I wasnât asked if I was a student or a PI, I was more proud to say that suadero (pronounced swa-day-ro), fatty, with meat caramelized in its own fat, tender, andâoh, did I say
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Read the Premium edition here ⤠What our members say đŁď¸ "Dr.
- Understanding Biased Signaling in GPCRs
Explore the library ⤠What Members Say âDr.
- How System-Level GPCR Thinking Prevents Discovery Failures
đ Access this weekâs full Premium Edition here ⤠What Members Say "I am a convert! I will keep Dr.
- How Schild Analysis Protects Your Conclusions in GPCR Research
đ Access this weekâs full Premium Edition here ⤠What Members Say âDr.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Access this weekâs full Premium Edition here ⤠What our members say "I am a convert!
- GPCR Selectivity Beyond the Receptor â Live April 9th with Bryan Roth
Explore the library ⤠What Members Say The Dr.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Register for Discovery On Target ⤠What our community is saying âI enjoy the breadth of questioning that
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Access this weekâs full Premium Edition here ⤠What our members say "Thank you for bringing this course
- GPCR Selectivity Beyond the Receptor
Explore Library â What Members Say The scientists in this community hold teaching to the same standard
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Potency does not,â says Kenakin.
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Access this weekâs full Premium Edition here ⤠What our members say "The content had enough depth to
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Access this weekâs full Premium Edition here ⤠What our members say "Dr.






























